Publications
Journal Articles
7/10/2023
O'Halloran JA, Ko ER, Anstrom KJ, Kedar E, McCarthy MW, Panettieri RA, Maillo M, Nunez PS, Lachiewicz AM, Gonzalez C, Smith PB, de Tai SM, Khan A, Lora AJM, Salathe M, Capo G, Gonzalez DR, Patterson TF, Palma C, Ariza H, Lima MP, Blamoun J, Nannini EC, Sprinz E, Mykietiuk A, Alicic R, Rauseo AM, Wolfe CR, Witting B, Wang JP, Parra-Rodriguez L, Der T, Willsey K, Wen J, Silverstein A, O'Brien SM, Al-Khalidi HR, Maldonado MA, Melsheimer R, Ferguson WG, McNulty SE, Zakroysky P, Halabi S, Benjamin DK, Butler S, Atkinson JC, Adam SJ, Chang S, LaVange L, Proschan M, Bozzette SA, Powderly WG, . "Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial." JAMA.. 2023 Jul 10; Epub 2023 Jul 10.
10/13/2022
Rein L, Calero K, Shah R, Ojielo C, Hudock KM, Lodhi S, Sadaka F, Bellam S, Palma C, Hager DN, Daniel J, Schaub R, O'Hayer K, Theodoropoulos NM. "Randomized Phase 3 Trial of Ruxolitinib for COVID-19-Associated Acute Respiratory Distress Syndrome." Critical care medicine.. 2022 Oct 13; Epub 2022 Oct 13.
9/26/2022
O'Halloran J, Kedar E, Anstrom KJ, McCarthy MW, Ko ER, Segura Nunez P, Boucher C, Smith PB, Panettieri RA, Mendivil Tuchia de Tai S, Maillo M, Khan A, Mena Lora AJ, Salathe M, Capo G, Rodriguez Gonzalez D, Patterson TF, Palma C, Ariza H, Patelli Lima M, Lachiewicz AM, Blamoun J, Nannini E, Sprinz E, Mykietiuk A, Alicic R, Rauseo AM, Wolfe CR, Wittig B, Benjamin DK, McNulty SE, Zakroysky P, Halabi S, Butler S, Atkinson J, Adam SJ, Melsheimer R, Chang S, LaVange L, Proschan M, Bozzette SA, Powderly WG. "Infliximab for Treatment of Adults Hospitalized with Moderate or Severe Covid-19." medRxiv : the preprint server for health sciences.. 2022 Sep 26; Epub 2022 Sep 26.
VIEW ALL PUBLICATIONS